×

News

Post image
Patients with erectile dysfunctions and multiple comorbidities: A look into drug-related problems

Huri HZ and co-authors conducted a study in a tertiary medical center in Kuala Lumpur, Malaysia, wherein a total of 200 erectile dysfunction (ED) patients with 499 cases who had received pharmacological treatments for their ED participated in this study. Types, causes and factors associated with drug-related problems (DRPs) in ED patients with multiple comorbidities were evaluated.

Nov 10, 2021

Post image
Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder: Randomized, placebo-controlled, double-blind, parallel group clinical study

Bray R and co-authors evaluated the effect of tolterodine extended release (TER) versus placebo on bladder wall thickness (BWT) using transvaginal ultrasound in women with overactive bladder (OAB). They recruited 79 women with symptoms of OAB with a mean age of 47 years who had a BWT of at least 5 mm and a post-micturition volume of less than 50 mL at screening.

Nov 10, 2021

Post image
Traditional and Emerging Surgical Therapies for Lower Urinary Tract Symptoms in Men: A comparative review

Lower urinary tract symptoms (LUTS) are one of the most common health problems in men and pose a significant economic challenge in healthcare. Transurethral resection of the prostate (TURP) remains the gold standard surgical treatment for medically refractive LUTS secondary to benign prostatic hyperplasia (BPH).

Nov 10, 2021

Post image
Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment

Kim and co-authors conducted a prospective, multi-centre clinical study to identify incidence and risk factors of recurrence after discontinuation of successful antimuscarinic therapy in patients with overactive bladder (OAB). Patients who had antimuscarinic agents for > 12 weeks and showed successful response were included.

Nov 10, 2021

Success

You just clicked the toast button, this toast will be closed in 2s..

×